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INTRODUCTION
Hypopharyngeal squamous cell carcinoma (HPSCC) is one of 
the most aggressive cancers of the head and neck area with a 
poor prognosis due mainly to an advanced stage at the time of 
initial diagnosis (1). The 5-year survival rate of HPSCC patients 
with advanced tumors has been reported to be less than 30% (2, 
3). Thus, it is very important to detect the tumor at an early stage 
to increase the cure rate. However, small HPSCC (T1 or T2) is 
rare, because it is not until the tumor becomes fairly large that 
patients experience symptoms. 
 Although there is still debate surrounding which treatment 
modality is optimal for treating small HPSCC, organ preserva-
tion therapies such as radiotherapy, chemotherapy, or combined 
chemoradiotherapy have become more popular than surgery in 
recent years (4, 5). This is probably due to the fact that postoper-
ative functional results, including voice sacrifice from total laryn-
gectomy, are far more severe than those obtained using (chemo) 
radiotherapy, even though the survival rates are equivalent. How-
ever, (chemo) radiotherapy can result in significant morbidities 
from xerostomia, dysphagia, or mucositis (6, 7). Furthermore, 
surgical salvage of patients with recurrence has an extremely 
poor cure rate (8).
 The lateral pharyngotomy approach is a well-known surgical 
approach for selected malignant tumors of hypopharynx (9). 
Objectives. To evaluate the oncologic and functional results of larynx-preserving partial pharyngectomy (LPP) via lateral 
pharyngotomy approach as a primary treatment for small (T1 or T2) hypopharyngeal squamous cell carcinoma (HP-
SCC). 
Methods. We performed a retrospective review of 23 patients who underwent LPP through lateral pharyngotomy approach 
for small HPSCC at the our department between January 1991 and June 2007. Fourteen (61%) patients had adju-
vant postoperative radiotherapy. 
Results. The 2-years and 5-years disease specific survival rate was 77% and 61%, respectively. Nine patients (39%) had tu-
mor recurrence. The most common pattern of recurrence was isolated distant failure (n=4, 44%) followed by local 
(n=2, 22%) and loco-regional (n=3, 34%) recurrence. The ultimate cure rate of the primary tumor was 87% (20 of 
23). Twenty-two of the 23 patients (95%) could be decannulated, tolerate an oral diet, and had acceptable postopera-
tive phonatory function. 
Conclusion. LPP via lateral pharyngotomy approach appears to be a feasible procedure for selected small HPSCC patients 
in terms of both oncologic and functional outcomes.
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Recently, this procedure can be applied to to resection of oro-
pharynx cancer (10). 
 Unfortunately, few articles regarding larynx-preserving surgery 
through lateral pharyngotomy approach as a primary treatment 
for small HPSCC exist because patients with early tumors are 
rare and because (chemo) radiation is most often used for pri-
mary treatment. Recently, larynx-preserving surgery, including 
laser surgery, robot surgery, and endoscopic tumor resection, 
have been attempted (11-13). These studies, however, only in-
cluded a limited subset of patients. Therefore, in this study, we 
evaluated the oncologic and functional results of larynx-preserv-
ing partial pharyngectomy (LPP) performed using lateral phar-
yngotomy approach as a primary treatment for small HPSCC. 
MATERIALS AND METHODS
We performed a retrospective review of 133 previously-untreat-
ed consecutive HPSCC patients who visited the Department of 
Otorhinolaryngology, Yonsei University, Seoul, Korea, between 
January 1991 and June 2007. Patients who had a large primary 
tumor (T3 or T4; n=52), who were undergoing chemotherapy 
or radiotherapy as a primary treatment (n=21), who required 
more than a total laryngectomy for small HPSCC (n=20), who 
had a second primary HPSCC (n=7), who had distant metasta-
sis at initial presentation (n=5), or who had non-squamous cell 
carcinoma (n=2) were excluded, thus 107 patients were exclud-
ed in total. Of the remaining 26 patients, 3 patients who under-
went LPP via supraglottic laryngectomy approach were also ex-
cluded. Therefore, a total of 23 patients were enrolled in this 
study. LPP via lateral pharyngotomy approach was performed 
in patients with a tumor less than T2 without impairment of vo-
cal cord movement if 1) the primary lesion was confined to the 
lateral wall of the pyriform sinus with no involvement of the 
pyriform apex, 2) the primary lesion was confined to the medial 
wall of the pyriform sinus with no involvement of the paraglot-
tic space, or 3) the primary lesion was confined to the posterior 
pharyngeal wall without extension to the upper boundary of 
the cricoid cartilage with no involvement of the medial wall of 
the pyriform sinus. Preoperative staging was performed by phys-
ical examination, endoscopy, computed tomography, and/or 
magnetic resonance imaging. All patients were re-staged accord-
ing to the system determined by the 2002 American Joint Com-
mittee on Cancer.
 All patients received a lateral pharyngotomy approach accord-
ing to the previously described surgical procedure (14). Twenty-
two (95%) patients underwent neck dissections. The neck dis-
sections were elective or therapeutic, based on the absence or 
presence of clinically metastatic lymph nodes, respectively, re-
sulting in 12 elective (52%) dissections and 10 (48%) dissec-
tions for therapeutic management. Fourteen patients (60%) were 
treated with bilateral neck dissections. To reconstruct the surgi-
cal defect area, a forearm free flap was used in 16 patients (69%) 
and a split thickness skin graft was used in 2 patients (8%). Pri-
mary closure was performed in the remaining five patients (25%). 
Surgery alone was used to treat 9 patients (39%). Fourteen 
(61%) patients with pathologic lymph node metastases or a 
positive resection margin of the primary tumor received postop-
erative adjuvant radiotherapy. The radiation dose ranged from 
5,040 to 6,900 cGy (mean, 5,875 cGy). The mean follow-up pe-
riod was 50 months, ranging from 5 to 132 months. All patients 
were followed–up for a minimum of 2 years or until death. Dis-
ease-specific survival rates were evaluated by Kaplan Meier 
analysis using SPSS ver. 13.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
Patient and tumor characteristics
All patients were male with a median age of 61 years (range, 39 
to 78 years). Table 1 summarizes the subsites of primary tumors 
in our study. Clinical and pathologic tumor stages are depicted 
in Table 2. In fourteen (61%) patients, the primary tumor had 
an exophytic growth pattern and in 9 patients, an infiltrative 
pattern. The tumor grade was moderately differentiated in 12 
patients, well differentiated in 7 patients, and poorly differenti-
ated in 3 patients. The single remaining patient had an undiffer-
entiated primary tumor. Eleven (48%) patients had pathologi-
cally-confirmed metastatic neck lymph nodes. Occult neck me-
Table 1. Subsites of primary tumors
Subsites No. (%)
Lateral wall of the pyriform sinus 8 (35)
Medial wall of the pyriform sinus 3 (13)
Posterior hypopharyngeal wall 12 (52)
Total 23 (100)
Table 2. Clinical and pathologic tumor stages
 (A) Clinical stages
T1 T2 Total
N0 5 8 13
N1 0 2 2
N2a 2 0 2
N2b 2 3 5
N2c 0 1 1
Total 9 14 23
 (B) Pathologic tumor node stages
T1 T2 T3 T4 Total
N0 5 4 2 1 12
N1 0 0 0 0 0
N2a 0 0 0 0 0
N2b 2 5 2 0 9
N2c 0 1 1 0 2
Total 7 10 5 1 23
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tastasis was found in one patient (1 of 12, 8%) with elective 
neck dissection. Nine patients (39%) had a positive resection 
margin.
Survival and recurrence
The 2-year and 5-year disease specific survival rate (DSSR) was 
77% and 61%, respectively (Fig. 1). Nine patients (39%) had 
tumor recurrence. Table 3 shows the recurrence patterns in our 
patients. Local recurrence developed in one of nine patients 
(11%) with a positive surgical margin after adjuvant radiothera-
py. The sites of distant metastasis were the lung (n=2), bone 
(n=1), and liver (n=1). A second primary head and neck cancer 
developed in two patients (7%) over a follow-up period of 61 
and 72 months, respectively. These second primary cancers oc-
curred in the tonsils and false vocal cord, respectively. Salvage 
treatment was attempted in 5 patients (55%) to cure the dis-
ease. Of the remaining 4 patients with a recurrent tumor, three 
patients received only conservative care and one patient refused 
all treatments. Of the 5 patients who underwent salvage treat-
ments, successful salvage was achieved in 2 patients (40%). One 
local recurrence and one locoregional recurrence was observed 
in these 2 patients. Thus, of 5 patients with a local or locoregion-
al recurrence, 2 patients were ultimately cured. The ultimate cure 
rate of the primary tumor in our study was 87% (20 of 23). 
Postoperative complications and functional results
Table 4 shows the postoperative complications we encountered. 
There was no death in the immediate postoperative period. The 
two patients with flap dehiscence underwent further reconstruc-
tions using a pectoralis myocuteneous flap. Twenty-two of 23 
patients (95%) could be decannulated and could tolerate an oral 
diet. The average time until decannulation and starting an oral 
diet was 28 days (range, 11 to 113 days) and 17 days (range, 11 
to 30 days), respectively. All patients had acceptable postopera-
tive phonatory functions except for one patient who failed to 
decannulate. A single patient was ultimately unable to decannu-
late and eat food through an oral route simultaneously. The pri-
mary lesion site of this patient with a pathologic T2N2b stage 
tumor was in the posterior pharyngeal wall; he received forearm 
free flap reconstruction for the pharyngeal wall defect after sur-
gery. 
DISCUSSION
There is no consensus on whether primary surgery or (chemo) 
radiotherapy is more effective for curing patients with HPSCC, 
especially early stages of this cancer, because of the absence of 
prospective randomized studies of surgery with or without adju-
vant radiotherapy versus (chemo) radiotherapy with or without 
salvage surgery. Thus, choice of the treatment modality depends 
largely on an institution’s preferences or entrenched beliefs in-
herited from teachers. Our institution prefers to treat HPSCC 
cases with primary surgery rather than (chemo) radiotherapy. 
 The 5-year DSSR of all 23 patients in our study were 61%, 
which falls within the wide range of 40% to 92% reported for 
conservative surgical treatment of HPSCC in previous studies 
(11, 15-17). The reason for this wide range of survival rates is 
probably due to the fact that different indications for larynx-pre-
serving surgery were used in the different studies, and it is likely 
that the postoperative pathologic stages also differed between 
studies. 
 If surgery is chosen as the primary treatment modality for 
small HPSCC, the extent of surgical resection that is needed to 
attain cure has to be decided on. Surgical options include partial 
pharyngectomy (PP), total laryngectomy and partial pharyngec-
tomy (TLPP), and total laryngopharyngectomy (TLP), depend-
ing on the site of lesion. Czaja and Gluckman (16) evaluated 
surgical outcomes in 37 patients who underwent primary sur-
gery for small HPSCC. They observed that although all nine of 
their patients who underwent PP had a negative surgical margin, 
Table 3. Recurrence patterns 
Pattern No. (%)
Distant metastasis 4 (44)
Local 2 (22)
Loco-regional 3 (34)
Total 9 (100)
Table 4. Postoperative complications 
Patterns No. (%)
Flap dehiscence 2 (33)
Wound infection 2 (33)
Hematoma 1 (17)
Aspiration pneumonia 1 (17)
Total 6 (100)
Fig. 1. Five-years survival rate of all patients.
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four of them (44%) had a local recurrence leading to death. Fur-
thermore, they reported that small HPSCC patients who under-
went limited resection (PP) showed statistically significantly 
worse survival than those who underwent extensive resection 
(TLPP or TLP). Thus, they recommended a more extensive pro-
cedure with a wider margin for surgical treatment of small HP-
SCC. One generally accepted explanation for the high rate of 
local recurrence in small HPSCC patients is the high frequency 
of submucosal spread combined with multiple “skip lesions” or 
tumor satellites in these patients. We also observed a high rate 
(39%) of pathologically positive resection margins in our study, 
even when excision with a minimum 2 cm healthy margin was 
performed intraoperatively. Interestingly, all 9 patients with pos-
itive resection margin had adjuvant radiotherapy and only a sin-
gle patient (11%) developed a local recurrence. Positive surgical 
margins after resection of head and neck cancers, including hy-
popharynx cancer, are known to be strongly associated with lo-
cal recurrence. Our low rate of local recurrence in patients with 
a positive resection margin may be due to the use of adjuvant 
postoperative radiotherapy for small tumors (less than T2). In 
contrast, 4 of 9 small HPSCC patients (44%) treated by surgery 
alone had local or locoregional recurrences. Of these 4 patients, 
two patients died due to the disease. Consistent with our results, 
Frank et al. (18), in their study of outcomes after primary sur-
gery in 110 HPSCC patients, found that locoregional recurrenc-
es were more common in the surgery-only group than the post-
operative radiotherapy group (57% vs. 14%, respectively; 
P<0.0001). In addition, they reported adjusted 5-year survival 
rates of 18% and 48% (P<0.05) for the surgery and postopera-
tive radiotherapy groups, respectively. Thus, postoperative radio-
therapy treatment may improve the survival of small HPSCC 
patients with risk factors after primary larynx-conserving sur-
gery via lateral pharyngotomy. 
 Notably, even for small primary tumors, nearly half of the re-
currence sites were distant (4 of 9 patients) without local or re-
gional recurrence. The hypopharynx is the site at highest risk of 
subsequent distant metastases for other head and neck areas, 
with a relative risk of >10-fold when compared with that of oral 
cavity cancer, which has the lowest risk (19). Leon et al. (20) 
also found that cancer of the hypopharynx or supraglottis was 
an independent risk factor for distant metastases. Taken togeth-
er, additional treatment strategies should be considered for pre-
venting distant metastases in HPSCC patients, even in those 
with small cancer. 
 Very few researchers have evaluated functional outcomes af-
ter LPP for small HPSCC. Wang et al. (21), based on a series of 
206 patients who underwent larynx-preserving surgery for HP-
SCC, observed that 67 patients (33%) required a permanent 
tracheostomy. Goepfert et al. (22) reported a rate of persistent 
aspiration of 11% and fatal pulmonary complications in patients 
who underwent conservative surgery for cancer of the hypo-
pharynx. However, Laccourreye reported that all patients treat-
ed with supracricoid hemilaryngopharyngectomy for HPSCC 
were decannulated and could tolerate an oral diet without gas-
trostomy or completion total laryngectomy (91.9% of patients); 
aspiration-related deaths only occurred in 0.7% of patients (23). 
Notably, Holsinger et al. (24) reported that all 30 patients receiv-
ing LPP by means of lateral pharyngotomy approach were decan-
nulated and no patients required a gastrostomy and/or comple-
tion total laryngectomy for functional reasons. We found that al-
most all our patients (96%) could be decannulated, tolerate an 
oral diet without gastrostomy, and communicate effectively. Fail-
ure of decannulation and lack of ability to tolerate an oral diet 
occurred only in a single patient. The reason for this may be that 
the reconstructed free flap was too large (4×4 cm) compared to 
the defect area of the posterior hypopharyngeal wall (2×2.5 cm) 
after resection in this patient, leading to a restricted airway and 
difficulty swallowing. Thus, it is crucial to design a flap of appro-
priate size for reconstruction of the hypopharyngeal defect after 
partial pharyngectomy. 
 In conclusion, we found that LPP using an lateral pharyngoto-
my approach for selected small HPSCC patients is a feasible 
procedure with respect to oncologic and functional outcomes. 
This study, however, has the limitations of a small number of en-
rolled patients and a retrospective study design. Prospective ran-
domized control studies with a large patient population are re-
quired to verify our findings.
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